Laurus Labs acquires 26.62% stake in ImmunoACT for Rs 46 crore

Additionally, Laurus Labs#39; senior management will also invest in ImmunoACT for a 5.64 percent stake for approximately Rs 9.75 crore at the same price and terms, the company said in a BSE filing

from Moneycontrol Business News https://ift.tt/30D6z4C